Skip to content
Ganga Pharmaceuticals logo

Ganga Pharmaceuticals

539680 BSE
₹12.50 up 0.50 (4.17%)
Market Cap
₹7.40 Cr
P/E
125.00

Ganga Pharmaceuticals (GANGAPHARM) share price was ₹12.50 at the 8 Sep 2026 close; market capitalisation ₹7.40 Cr; P/E (TTM) 125.00; sector Healthcare. In the Mar 2026 quarter, revenue rose 9.8% year on year to ₹1.46 Cr and net profit was ₹0.08 Cr, against ₹0.06 Cr a year earlier (compared with Mar 2025). Promoters held 50.91% of Ganga Pharmaceuticals in Sep 2026, unchanged from Mar 2026.

Close 8 Sep 2026 ₹12.50 +0.82 +7.02% 1Y

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹7.40 Cr
P/E (TTM)
125
EBITDA
₹30.00 L
Return on Equity
1.22%
Debt to Equity
0.13
Book Value
₹14.06
EPS (TTM)
₹0.10
52W High
₹13.97
52W Low
₹9.35

Last traded 10 Sep 2026 · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,764.0034.994,23,243 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,667.5087.742,56,642 Cr15.310.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,590.6072.071,74,612 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,194.10108.401,18,550 Cr22.370.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.9026.341,18,094 Cr4.360.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.7032.721,10,329 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Ganga Pharmaceuticals (this company)
₹12.50125.007 Cr0.890.00%1.22%3.12%2 Cr0 Cr
Median 8 companies₹1,564.8553.531,18,322 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.89 times its book value

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 3.30% over past five years.
  • Company has a low return on equity of 1.09% over last 3 years.
  • Promoter holding has decreased over last 3 years: -15.8%

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
6
Bullish
3

Overall

Bearish

Bearish
8
Neutral
6
Bullish
5

Moving Averages

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
0% lower than 3Y

change over 1 year

Net Income Growth
0% lower than 3Y

change over 1 year

Cash Flow Change
-126%

change over 1 year

EBITDA Margin Change
-1.54%

change over 1 year Operating margin 4.79% · Mar 2026

Quarterly Results

Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
1.7
1.14
1.23
1.25
1.24
1.35
1.23
1.32
1.42
1.31
1.33
1.37
1.46
Expenses
1.6
1.07
1.28
1.23
1.23
1.28
1.3
1.27
1.41
1.42
1.33
1.39
1.39
Operating Profit
0.1
0.07
-0.05
0.02
0.01
0.07
-0.07
0.05
0.01
-0.11
0
-0.02
0.07
OPM %
5.88%
6.14%
-4.07%
1.6%
0.81%
5.19%
-5.69%
3.79%
0.7%
-8.4%
0%
-1.46%
4.79%
Other Income
0.09
0.07
0.19
0.11
0.15
0.12
0.18
0.09
0.15
0.29
0.14
0.15
0.13
Interest
0.12
0.09
0.1
0.1
0.09
0.12
0.07
0.09
0.09
0.09
0.09
0.07
0.07
Depreciation
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.03
0.03
PBT
0.04
0.02
0.01
0
0.04
0.04
0.01
0.02
0.05
0.07
0.03
0.03
0.1
Tax %
25%
50%
100%
—
25%
25%
0%
50%
20%
57.14%
-66.67%
33.33%
20%
Net Profit
0.03
0.02
0
0
0.03
0.03
0.01
0.02
0.03
0.02
0.06
0.02
0.08
EPS (₹)
0.07
0.05
0
0
0.07
0.07
0.02
0.05
0.06
0.04
0.12
0.03
0.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
2.44
2.45
2.63
2.73
3.18
2.99
2.27
2.32
2.47
2.58
2.48
2.67
Expenses
2.19
2.15
2.32
2.41
2.76
2.61
2.24
2.28
2.47
2.53
2.6
2.63
Operating Profit
0.25
0.3
0.31
0.32
0.42
0.38
0.03
0.04
0
0.05
-0.12
0.04
OPM %
10.25%
12.24%
11.79%
11.72%
13.21%
12.71%
1.32%
1.72%
0%
1.94%
-4.84%
1.5%
Other Income
0.17
0.14
0.16
0.15
0.14
0.17
0.25
0.26
0.3
0.24
0.44
0.28
Interest
0.33
0.33
0.32
0.28
0.25
0.24
0.19
0.19
0.19
0.18
0.18
0.13
Depreciation
0.04
0.04
0.04
0.06
0.05
0.05
0.05
0.05
0.06
0.05
0.05
0.06
PBT
0.05
0.07
0.11
0.13
0.26
0.26
0.04
0.06
0.05
0.06
0.09
0.13
Tax %
40%
28.57%
27.27%
23.08%
30.77%
23.08%
50%
16.67%
40%
33.33%
11.11%
23.08%
Net Profit
0.03
0.05
0.07
0.09
0.19
0.19
0.02
0.04
0.04
0.05
0.08
0.1
EPS (₹)
0.13
0.12
0.17
0.22
0.47
0.47
0.05
0.1
0.1
0.1
0.17
0.17
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.33
4.06
4.06
4.06
4.06
4.06
4.06
4.06
4.06
4.84
4.84
5.91
Reserves
0.31
0.74
0.81
0.91
1.09
1.29
1.31
1.35
1.39
2.21
2.29
2.4
Borrowings
2.14
2.19
2.14
2.05
1.87
1.47
1.73
1.93
1.83
1.36
1.42
1.09
Other Liabilities
0.61
0.35
0.6
1.22
0.74
0.75
0.56
0.66
0.71
0.24
0.42
0.25
Total Liabilities
5.39
7.34
7.61
8.24
7.76
7.57
7.66
8
7.99
8.65
8.97
9.65
Fixed Assets
0.65
0.62
0.62
0.82
0.8
0.76
0.72
0.68
0.64
0.61
0.66
0.65
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.05
0.5
0
0
0.09
0.09
0.09
0.09
0.09
0.09
0
0
Other Assets
4.69
6.22
6.99
7.42
6.87
6.72
6.85
7.23
7.26
7.95
8.31
9
Total Assets
5.39
7.34
7.61
8.24
7.76
7.57
7.66
8
7.99
8.65
8.97
9.65
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.27
-1.05
0.05
0.24
0.11
-0.31
-0.18
-0.21
-0.04
-1.26
-0.58
-1.31
Investing
-0.18
-0.83
0.62
-0.14
0.28
0.37
0.28
0.19
0.49
0.13
1.18
0.24
Financing
-0.06
1.9
-0.33
-0.36
-0.45
-0.29
-0.1
0.03
-0.44
1.14
-0.33
0.82
Net Cash Flow
0.03
0.02
0.33
-0.26
-0.05
-0.22
0
0.01
0.01
0
0.27
-0.24
Free Cash Flow
0.23
-1.06
0.01
-0.02
0.08
-0.32
-0.2
-0.22
-0.05
-1.28
-0.68
-1.35
CFO/OP
104
-347
29
88
40
-66
-567
-500
—
-2,480
467
-3,200
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
109
140
173
211
141
131
132
140
132
130
134
129
Inventory Days
288
375
386
359
341
297
333
331
347
362
353
329
Days Payable
118
98.65
183
330
163
160
130
152
171
29.2
83.77
33.69
Cash Conversion Cycle
279
416
377
240
319
267
335
318
308
463
403
423
Working Capital Days
142
468
429
417
388
449
478
503
477
639
731
856
ROCE %
8.03%
6.8%
6.14%
5.84%
7.26%
7.23%
3.3%
3.46%
3.28%
3.06%
3.18%
2.9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ganga Pharmaceuticals insights

58 extracted metrics + investor summaries across FY15–FY26.

Shareholding Pattern

Promot.50.91%Others13.77%Public35.32%As ofSep 2026

Documents

Frequently Asked Questions about Ganga Pharmaceuticals

What does Ganga Pharmaceuticals Ltd do?
Incorporated in 1989, Ganga Pharmaceuticals Ltd manufactures & trades in Pharmaceuticals & allied products (Ayurveda)[1]
Where is Ganga Pharmaceuticals Ltd (GANGAPHARM) listed?
Ganga Pharmaceuticals Ltd trades under code 539680 on the BSE.
Which sector does Ganga Pharmaceuticals Ltd belong to?
Ganga Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd has a market capitalisation of ₹7.4 Cr as of 10 Sep 2026, which places it in the Small Cap band.
What is the PE ratio of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd trades at a PE ratio of 125.00 as of 10 Sep 2026, on earnings per share of ₹0.1, against a book value of ₹14.06 per share.
What is the 52-week high and low of Ganga Pharmaceuticals Ltd?
Over the last 52 weeks Ganga Pharmaceuticals Ltd has traded between ₹9.35 and ₹13.97 as of 10 Sep 2026.
What is the Return on Equity (ROE) of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd reported a return on equity of 1.22%. Its debt-to-equity ratio is 0.13.

Company Information

Incorporated in 1989, Ganga Pharmaceuticals Ltd manufactures & trades in Pharmaceuticals & allied products (Ayurveda)[1]

Website ayurvedganga.com
Listed 2016-02-22
Face Value ₹ 10
Shares Outstanding 59,20,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539680.md for Ganga Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month